Product image of Medimibi (Tetrafluoroborate) supplied by GNH India

Medimibi

Active Ingredient:
Tetrafluoroborate
Origin:
EU

Medimibi (Tetrafluoroborate)

Tetrafluoroborate, the active ingredient in Medimibi, is a pharmaceutical agent presented as an intravenous formulation for clinical use. Specific therapeutic applications have not been publicly disclosed.
GNH India supplies Medimibi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Radiopharmacy Laboratórium Kft.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Medimibi is an investigational intravenous agent whose clinical applications are currently limited to research settings.

  • Research Use: Enables evaluation of pharmacological properties in controlled clinical studies
  • Diagnostic Support: May be employed as a tracer or contrast agent in specialized imaging protocols
  • Experimental Therapy: Investigated for potential therapeutic effects in early‑phase trials

How It Works

  • The precise pharmacological mechanism of Tetrafluoroborate in Medimibi has not been publicly disclosed. Available information suggests it interacts with cellular pathways following intravenous administration, but detailed target receptors or molecular actions remain undefined.

Side Effects

Adverse reactions associated with Medimibi have not been fully characterized in publicly available literature.

Common Side Effects

  • Injection site discomfort: mild pain or irritation at the site of administration
  • Transient headache: short‑lasting headache reported in some recipients
  • Nausea: occasional feeling of nausea following infusion

Serious or Rare Side Effects

  • Hypersensitivity reaction: signs may include rash, itching, or swelling
  • Cardiovascular instability: rare reports of blood pressure fluctuations
  • Renal impairment: potential impact on kidney function in susceptible individuals

Precautions & Warnings

When handling Medimibi, consider the following precautions:

  • Patient assessment: evaluate medical history before administration
  • Monitoring: observe vital signs during and after infusion
  • Contraindications: avoid use in individuals with known hypersensitivity to the product
  • Drug interactions: review concomitant medications for potential conflicts
  • Pregnancy and lactation: use only if benefits outweigh potential risks
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake

Avoid Interactions

Potential drug interactions with Medimibi have not been comprehensively documented.

Major Interactions (Avoid)

  • Known hypersensitivity agents: concurrent use may increase risk of severe allergic response
  • Strong immunosuppressants: could amplify immunological effects

Moderate Interactions (Monitor Closely)

  • Anticoagulants: monitor coagulation parameters during therapy
  • Nephrotoxic drugs: assess renal function if combined
  • Hepatotoxic agents: observe liver enzymes when co‑administered
  • Electrolyte‑altering medications: watch for electrolyte imbalances

Frequently Asked Questions

Medimibi is an investigational intravenous product primarily used in clinical research settings to explore its pharmacological properties and potential therapeutic applications. It is not approved for routine clinical treatment.

The exact mechanism of action of Tetrafluoroborate in Medimibi has not been publicly disclosed. Current information indicates it interacts with cellular pathways after intravenous delivery, but specific targets remain undefined.

Dosing of Medimibi is determined by the prescribing investigator or clinician based on the study protocol or clinical judgment. No standardized dosing regimen is publicly available.

Safety data for Medimibi in pregnancy or lactation are limited. It should only be used if the potential benefits justify any possible risks to the mother or infant, and under strict medical supervision.

To order Medimibi, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Comparative data for Medimibi versus alternative investigational agents are limited. Differences may exist in molecular composition, pharmacokinetics, and safety profiles, which are evaluated on a case‑by‑case basis in clinical studies.

Medimibi must be stored at 2‑8 °C, kept refrigerated, protected from light, and should not be frozen or shaken. Follow all handling instructions provided with the product to maintain stability.

Medimibi is administered intravenously by a qualified healthcare professional. The infusion rate and duration are determined by the prescribing clinician according to the specific protocol.

Serious risks may include hypersensitivity reactions, cardiovascular instability, and potential renal impairment. Patients should be closely monitored during and after infusion for any adverse events.

Individuals with known hypersensitivity to any component of Medimibi, or those for whom the investigational product poses an undue risk, should not receive it. Clinical judgment is essential to determine suitability.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Tetrafluoroborate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT